These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9021706)

  • 1. What is the CLL B-lymphocyte?
    Dighiero G; Kipps T; Schroeder HW; Chiorazzi N; Stevenson F; Silberstein LE; Caligaris-Cappio F; Ferrarini M
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():13-39. PubMed ID: 9021706
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.
    Lanemo Myhrinder A; Hellqvist E; Bergh AC; Jansson M; Nilsson K; Hultman P; Jonasson J; Buhl AM; Bredo Pedersen L; Jurlander J; Klein E; Weit N; Herling M; Rosenquist R; Rosén A
    Leuk Lymphoma; 2013 Aug; 54(8):1769-79. PubMed ID: 23297799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
    Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
    Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
    Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
    J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.
    Nakhla PS; Butera JN; Treaba DO; Castillo JJ; Quesenberry PJ
    Leuk Lymphoma; 2013 Aug; 54(8):1647-51. PubMed ID: 23185961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.
    Schiemann WP; Rotzer D; Pfeifer WM; Levi E; Rai KR; Knaus P; Kadin ME
    Cancer Detect Prev; 2004; 28(1):57-64. PubMed ID: 15041079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
    Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
    Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells.
    Bueso-Ramos CE; Ferrajoli A; Medeiros LJ; Keating MJ; Estrov Z
    Hematology; 2004 Aug; 9(4):279-86. PubMed ID: 15621735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
    Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
    Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
    Pluta A
    Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
    [No Abstract]   [Full Text] [Related]  

  • 13. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of B cell growth and maturation factor on B-CLL lymphocytes.
    Karray S; Emilie D; Galanaud P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):275-8. PubMed ID: 3065728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SnapShot: chronic lymphocytic leukemia.
    Ciccone M; Ferrajoli A; Keating MJ; Calin GA
    Cancer Cell; 2014 Nov; 26(5):770-770.e1. PubMed ID: 25517752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2 tyrosine kinase mediates integrin activation induced by CXCL12 in B-cell chronic lymphocytic leukemia.
    Montresor A; Toffali L; Mirenda M; Rigo A; Vinante F; Laudanna C
    Oncotarget; 2015 Oct; 6(33):34245-57. PubMed ID: 26413812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.
    Kronenberger K; Nössner E; Frankenberger B; Wahl U; Dreyling M; Hallek M; Mocikat R
    J Immunother; 2008 Oct; 31(8):723-30. PubMed ID: 18779747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.